| Primary |
| Hyperparathyroidism Secondary |
43.9% |
| Product Used For Unknown Indication |
37.8% |
| Drug Use For Unknown Indication |
5.1% |
| Hypertension |
3.1% |
| Hyperphosphataemia |
2.6% |
| Prostate Cancer Metastatic |
1.5% |
| Secondary Hypothyroidism |
1.5% |
| Hypoparathyroidism |
1.0% |
| Fatigue |
0.5% |
| Hyperparathyroidism |
0.5% |
| Insomnia |
0.5% |
| Lymphoma |
0.5% |
| Off Label Use |
0.5% |
| Renal Failure |
0.5% |
| Renal Failure Chronic |
0.5% |
|
| Pancreatitis Acute |
15.4% |
| Respiratory Distress |
9.2% |
| Blood Calcium Increased |
6.2% |
| Sepsis |
6.2% |
| Vomiting |
6.2% |
| Abdominal Pain Upper |
4.6% |
| Abortion Spontaneous |
4.6% |
| Anaphylactic Reaction |
4.6% |
| Cardiopulmonary Failure |
4.6% |
| Drug Hypersensitivity |
4.6% |
| Pruritus |
4.6% |
| Staphylococcal Infection |
4.6% |
| Blood Albumin Decreased |
3.1% |
| Death |
3.1% |
| Drug Ineffective |
3.1% |
| Hypercalcaemia |
3.1% |
| Medical Device Complication |
3.1% |
| Nipple Pain |
3.1% |
| Overdose |
3.1% |
| Serum Ferritin Increased |
3.1% |
|
| Secondary |
| Hyperparathyroidism Secondary |
34.8% |
| Product Used For Unknown Indication |
33.7% |
| Crohn's Disease |
4.3% |
| Hyperphosphataemia |
4.3% |
| Osteoporosis |
4.3% |
| Drug Use For Unknown Indication |
2.2% |
| Gastrooesophageal Reflux Disease |
2.2% |
| Gout |
2.2% |
| Haemoglobin Decreased |
2.2% |
| Hyperparathyroidism |
2.2% |
| Iron Deficiency Anaemia |
2.2% |
| Calcium Phosphate Product |
1.1% |
| Diabetes Mellitus |
1.1% |
| Nephrogenic Anaemia |
1.1% |
| Peritoneal Dialysis |
1.1% |
| Secondary Hypothyroidism |
1.1% |
|
| Drug Hypersensitivity |
18.5% |
| Overdose |
14.8% |
| Confusional State |
7.4% |
| Headache |
7.4% |
| Pruritus |
7.4% |
| Vomiting |
7.4% |
| Accidental Death |
3.7% |
| Back Pain |
3.7% |
| Blood Parathyroid Hormone Abnormal |
3.7% |
| Bone Disorder |
3.7% |
| Fatigue |
3.7% |
| Hypertension |
3.7% |
| Malaise |
3.7% |
| Medical Device Complication |
3.7% |
| Nausea |
3.7% |
| Rash Generalised |
3.7% |
|
| Concomitant |
| Drug Use For Unknown Indication |
50.1% |
| Product Used For Unknown Indication |
22.7% |
| Nuclear Magnetic Resonance Imaging |
5.5% |
| Peritoneal Dialysis |
4.4% |
| Hypertension |
2.8% |
| Pain |
1.9% |
| Prophylaxis |
1.5% |
| Renal Failure Chronic |
1.4% |
| Angiogram |
1.3% |
| Anaemia |
1.1% |
| Thrombosis Prophylaxis |
1.0% |
| Diabetes Mellitus |
0.9% |
| Haemodialysis |
0.9% |
| Supplementation Therapy |
0.9% |
| Nuclear Magnetic Resonance Imaging Brain |
0.7% |
| Blood Pressure |
0.6% |
| Hyperparathyroidism Secondary |
0.6% |
| Dialysis |
0.6% |
| Depression |
0.6% |
| Nausea |
0.6% |
|
| Vomiting |
30.1% |
| Peritonitis Bacterial |
7.1% |
| Skin Tightness |
5.0% |
| Renal Failure Chronic |
4.6% |
| Drug Ineffective |
4.2% |
| Peritonitis |
4.2% |
| Subcutaneous Nodule |
4.2% |
| Pyrexia |
3.8% |
| Unresponsive To Stimuli |
3.8% |
| Nausea |
3.3% |
| Nephrogenic Systemic Fibrosis |
3.3% |
| Renal Failure |
3.3% |
| Treatment Noncompliance |
3.3% |
| Death |
2.9% |
| Sepsis |
2.9% |
| Skin Induration |
2.9% |
| Swollen Tongue |
2.9% |
| Urinary Tract Infection |
2.9% |
| Angina Unstable |
2.5% |
| Hypotension |
2.5% |
|
